Sabra Health Care REIT, Inc. has reported a significant transaction involving its director, Michael J. Foster. On November 11, 2026, Foster sold 10,000 shares of the company’s common stock at a price of $20.98 per share. This transaction is noteworthy as it reflects ongoing changes in leadership and ownership within the company.

The sale leaves Foster with a total of 72,834 shares in Sabra Health Care REIT. The transaction may influence investor sentiment and confidence in the company, especially as it comes amid a backdrop of recent financial disclosures and market activities.

Background

Sabra Health Care REIT, Inc. operates in the Real Estate Investment Trusts sector, specifically focusing on healthcare-related properties. The company is listed on the Nasdaq under the ticker symbol SBRA. It is classified under the SIC code 6798, which pertains to Real Estate Investment Trusts. Sabra's recent filings indicate a proactive approach to managing its assets and investor relations.

What the Filing Says

According to the recent SEC filing (accession number 0001145246-26-000019), the transaction was categorized as a disposition of shares. The filing states, "Michael J. Foster sold 10,000 shares of common stock." Following this transaction, Foster retains ownership of 72,834 shares, which includes both vested and unvested stock units.

Impact

This sale may affect various stakeholders, including investors and analysts observing Sabra's stock performance. Changes in ownership by key executives can often signal shifts in confidence or strategy, which in turn may influence market perceptions of the company. As a significant player in the Real Estate Investment Trusts sector, Sabra's actions are likely to be closely watched by its competitors and investors alike.

What's Next

The filing does not say what happens next regarding further transactions or company strategy following this sale.